Medicaid Bulletin

Medicaid Bulletin Monthly Digest

Medicaid Bulletin Archive

Articles beginning January 2018 are available in the blog format.

SPECIAL BULLETIN COVID-19 #262: Extension of Flexibility for Opioid Treatment Program Take-Home Dosing Update
Flexibility sunset extended from June 30, 2022 to Aug. 15, 2022
FQHC Radiology Services Reimbursement Methodology Revision
Effective Aug. 1, 2022, only the technical component of an onsite radiology service performed at FQHCs/RHCs will be separately reimbursed by Medicaid
SPECIAL BULLETIN COVID-19 #261: New Moderna Pediatric Vaccine Codes
Three new vaccine codes for pediatric patients ages 6 through 11
SPECIAL BULLETIN COVID-19 #260: NC Medicaid Pharmacy Point-of-Sale Billing for Pharmacist-Prescribed Paxlovid
FDA authorizes Paxlovid for treatment of COVID-19 to be prescribed by pharmacists
Integrating Community Health Workers into NC Medicaid
Guidance published with examples, training and certification opportunities
Quarterly Drug HCPCS Code Update July 1, 2022
System updates are completed to align our policies with HCPCS code changes
Leuprolide Injectable Emulsion, for Subcutaneous Use (Camcevi™) HCPCS Code J1952: Billing Guidelines
Effective April 1, 2022, Medicaid and NC Health Choice cover leuprolide injectable emulsion
Lanreotide Injection, for Subcutaneous Use HCPCS Code J3490: Billing Guidelines
Effective April 18, 2022, Medicaid and NC Health Choice cover lanreotide injection
Facility-Based Crisis Service for Children and Adolescents Policy Updated
Effective May 15, 2022, technical changes were made to address access to care concerns.
SPECIAL BULLETIN COVID-19 #259: Mandatory Coverage of COVID-19-Related Treatment Under the American Rescue Plan Act of 2021 (UPDATE)
Guidance for NC Medicaid Direct and NC Medicaid Managed Care